Adrenal Gland Tumors
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| IDOV-Immune for Advanced Solid Tumors (NCT06910657) | ViroMissile, Inc. | 2025-08-25 |
| A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors (NCT00947167) | Pamela L. Kunz | 2009-03-01 |
Track Adrenal Gland Tumors automatically
Every clearance here is in the API, with alerts when new ones post.